CARDIOLOGIST Trial: Artificial Intelligence Enabled Electrocardiogram for Atrial Fibrillation Detection

Computer-assisted Atrial Fibrillation Risk Detection In Oral-anticoagulant Use, Lowering Stroke Risk, and Optimizing Guidance With an Intelligent Screening Tool (CARDIOLOGIST): a Pragmatic Randomized Controlled Trial

This is a randomized controlled trial (RCT) to test a novel artificial intelligence (AI)-enabled electrocardiogram (ECG)-based screening tool for improving the diagnosis and management of Atrial Fibrillation.

Inclusion Criteria:

• Patients in emergency department or inpatient department
• Patients had at least 1 ECG
• Patients cared by non-cardiologist

Exclusion Criteria:

• Patients without history of atrial fibrillation diagnosis.
• Patients without history of long-term NOAC or warfarin usage.
• Patients without history of hemorrhagic stoke or ishemic stroke.
• Patients with low eGFR (<30 ml/min)